ReviewNature reviews. Rheumatology2015
A new look at rheumatology in China--opportunities and challenges.
Review in Nature reviews. Rheumatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07045896 (Fucoidan Therapy in Adults With Active Rheumatoid Arthritis and Inadequate Response to Conventional DMARDs), which is not on this map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Fucoidan Therapy in Adults With Active Rheumatoid Arthritis and Inadequate Response to Conventional DMARDs: a Multicenter, Single-arm, Open-label, Phase 2 Trial
Who cites it
20 citing papers in PubMed.
- Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis.Chinese medical journal · 2018Trial
- Health service capacity of rheumatology and immunology departments in China: A cross-sectional study of young and middle-aged physicians.Rheumatology and immunology research · 2026Article
- Multiomics Analyses Reveal an Essential Role of Tryptophan in Treatment of csDMARDs in Rheumatoid Arthritis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Risk Factors of Progression to Active Tuberculosis in Rheumatic Patients With Latent Tuberculosis: A Retrospective Study.Immunity, inflammation and disease · 2025Article
- Dual-driven selenium Janus single-atom nanomotors for autonomous regulating mitochondrial oxygen imbalance to catalytic therapy of rheumatoid arthritis.Redox biology · 2025Article
- Comprehensive multi-omics analysis reveals the core role of glycerophospholipid metabolism in rheumatoid arthritis development.Arthritis research & therapy · 2023Article
- Inflammatory Cytokine-Neutralizing Antibody Treatment Prevented Increases in Follicular Helper T Cells and Follicular Regulatory T Cells in a Mouse Model of Arthritis.Journal of inflammation research · 2022Article
- Hypoxia Inhibits Osteogenesis and Promotes Adipogenesis of Fibroblast-like Synoviocytes via Upregulation of Leptin in Patients with Rheumatoid Arthritis.Journal of immunology research · 2022Article
- Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China.Rheumatology and therapy · 2021Article
- Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies.Acta pharmaceutica Sinica. B · 2021Review
- Healthcare disparities in rheumatology: the role of education at a global level.Clinical rheumatology · 2020Review
- Rheumatology in Ukraine.Rheumatology international · 2020Review
- Rheumatology in Egypt: back to the future.Rheumatology international · 2019Review
- Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes.Journal of immunology research · 2019Article
- Salvianolic Acid B Suppresses Inflammatory Mediator Levels by Downregulating NF-κB in a Rat Model of Rheumatoid Arthritis.Medical science monitor : international medical journal of experimental and clinical research · 2018Article
- [Intra-articular injection of ascorbic acid/ferric chloride relieves cartilage degradation in rats with osteoarthritis].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2018Article
- Brief report on academic contributions from China on the topic of rheumatic diseases.Zeitschrift fur Rheumatologie · 2017Article
- The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study.Clinical rheumatology · 2017Observational
- Status of rheumatology practice and professional training courses in rural areas of China-an ILAR project.Clinical rheumatology · 2017Article
- Professional Creators Provide Higher-Quality Ankylosing Spondylitis Content on TikTok and Bilibili: A Cross-Sectional Study.Inquiry : a journal of medical care organization, provision and financingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the past two decades, Chinese rheumatology has developed rapidly in terms of both clinical practice and basic research. Many rheumatology departments and divisions have been established, creating positions for more residents to join rheumatology practices. Numerous studies of rheumatic diseases have been published in recent years by Chinese rheumatologists and immunologists, supported by government funding that has dramatically increased over the past few years. These studies are focused mainly on epidemiology, mechanisms, early diagnosis and interventions of rheumatic diseases. Increasing numbers of national and international scientific activities in China, including research collaborations, education programmes and conferences have greatly helped the development of rheumatology. In this APLAR series article, the major, high-impact studies and latest developments in Chinese rheumatology are reviewed.
Indexed as
Identifiers
25599919What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.